metformin has been researched along with Ascites in 4 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
Excerpt | Relevance | Reference |
---|---|---|
"In vivo, treatment of an ovarian cancer mouse model with metformin resulted in greater tumor weight reduction in normoglycemic vs." | 5.42 | Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer. ( Eckert, MA; Johnson, A; Lengyel, E; Litchfield, LM; Mills, KA; Mukherjee, A; Pan, S; Romero, IL; Shridhar, V, 2015) |
"Ascites is associated with a high risk of death." | 1.72 | Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans. ( Mazumder, N; Parikh, ND; Tapper, EB; Zhao, Z, 2022) |
"Ovarian cancer is the most lethal gynecological malignancy in women." | 1.62 | Metformin Affects the Transcriptomic Profile of Chicken Ovarian Cancer Cells. ( Albert, I; Gopalan, L; Praul, CA; Ramachandran, R; Sebastian, A, 2021) |
"In vivo, treatment of an ovarian cancer mouse model with metformin resulted in greater tumor weight reduction in normoglycemic vs." | 1.42 | Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer. ( Eckert, MA; Johnson, A; Lengyel, E; Litchfield, LM; Mills, KA; Mukherjee, A; Pan, S; Romero, IL; Shridhar, V, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Gopalan, L | 1 |
Sebastian, A | 1 |
Praul, CA | 1 |
Albert, I | 1 |
Ramachandran, R | 1 |
Tapper, EB | 1 |
Zhao, Z | 1 |
Mazumder, N | 1 |
Parikh, ND | 1 |
Saffo, S | 1 |
Kaplan, DE | 1 |
Mahmud, N | 1 |
Serper, M | 1 |
John, BV | 1 |
Ross, JS | 1 |
Taddei, T | 1 |
Litchfield, LM | 1 |
Mukherjee, A | 1 |
Eckert, MA | 1 |
Johnson, A | 1 |
Mills, KA | 1 |
Pan, S | 1 |
Shridhar, V | 1 |
Lengyel, E | 1 |
Romero, IL | 1 |
4 other studies available for metformin and Ascites
Article | Year |
---|---|
Metformin Affects the Transcriptomic Profile of Chicken Ovarian Cancer Cells.
Topics: Animals; Ascites; Cell Line, Tumor; Cell Proliferation; Chickens; Down-Regulation; Epithelial-Mesenc | 2021 |
Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans.
Topics: Aged; Anticoagulants; Antiviral Agents; Ascites; Atorvastatin; Carvedilol; Diuretics; Fibrosis; Huma | 2022 |
Impact of SGLT2 inhibitors in comparison with DPP4 inhibitors on ascites and death in veterans with cirrhosis on metformin.
Topics: Ascites; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Huma | 2021 |
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer.
Topics: Animals; Antineoplastic Agents; Ascites; Cell Line, Tumor; Cell Survival; Female; Gene Expression Re | 2015 |